13F reference period
Q2 2026
CUSIP: 80880W205
13F reference period
Q2 2026
Institutions Reporting
70
Shares (Excl. Options)
Price
$7.80
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 70 institutions filings for Q2 2026.
Security key
80880W205
13F reference period
Q2 2026
13F holders
70
13D/G owners
3
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 80880W205:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | 11% | $234,280,198 | 30,029,378 | SCLX Stock Acquisition JV LLC | 03 Jul 2026 | |||
| ARMISTICE CAPITAL, LLC | 8.6% | $31,008,000 | 4,800,000 | Armistice Capital, LLC | 30 Jun 2025 | |||
| ORAMED PHARMACEUTICALS INC. | 4.9% | -50% | $5,438,249 | -$4,921,820 | 437,510 | -48% | Oramed Pharmaceuticals Inc. | 31 Dec 2025 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 27,349 | $120,753 | +$23,268 | $4.45 | 20 |
| 2026 Q2 | 702,606 | $5,480,420 | -$943,531 | $7.80 | 70 |
| 2026 Q1 | 871,717 | $5,805,880 | -$2,086,274 | $6.66 | 69 |
| 2025 Q4 | 1,119,739 | $13,661,197 | +$3,630,948 | $12.20 | 78 |
| 2025 Q3 | 759,753 | $14,960,373 | +$3,238,244 | $19.68 | 79 |
| 2025 Q2 | 619,696 | $3,649,745 | +$3,564,555 | $5.89 | 63 |
| 2025 Q1 | 42,004 | $10,442 | +$10,434 | $0.25 | 4 |
| 2024 Q4 | 19 | $8 | $0.42 | 1 | |
| 2024 Q3 | 19 | $18 | $0.95 | 1 | |
| 2024 Q2 | 19 | $37 | +$37 | $1.95 | 1 |